FSGEX
Price
$21.20
Change
+$0.16 (+0.76%)
Updated
Jun 2 closing price
Net Assets
74.28B
TBWCX
Price
$22.13
Change
+$0.24 (+1.10%)
Updated
Jun 2 closing price
Net Assets
470.99M
Interact to see
Advertisement

FSGEX vs TBWCX

Header iconFSGEX vs TBWCX Comparison
Open Charts FSGEX vs TBWCXBanner chart's image
FSGEX vs TBWCX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. TBWCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Buy and TBWCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.3B vs. TBWCX (471M). FSGEX pays higher dividends than TBWCX: FSGEX (2.64) vs TBWCX (0.33). FSGEX was incepted earlier than TBWCX: FSGEX (17 years) vs TBWCX (11 years). TBWCX (2.62) is less costly to investors than FSGEX (0.01). TBWCX is a more actively managed with annual turnover of: 39.30 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than TBWCX: FSGEX (0) vs TBWCX (5000). FSGEX annual gain was more profitable for investors over the last year : 32.37 vs. TBWCX (11.04). FSGEX return over 5 years is better than : 53.10 vs. TBWCX (9.34).
FSGEXTBWCXFSGEX / TBWCX
Total Expense Ratio0.011.951%
Annual Report Gross Expense Ratio0.012.620%
Fund Existence17 years11 years-
Gain YTD14.9733.012497%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets74.3B471M15,775%
Annual Yield % from dividends2.640.33808%
Returns for 1 year32.3711.04293%
Returns for 3 years72.1934.88207%
Returns for 5 years53.109.34569%
Returns for 10 years141.4577.89182%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIQT1.160.11
+10.07%
LiqTech International
MTUS20.360.80
+4.09%
Metallus
VEON55.300.21
+0.38%
VEON Ltd
RYAAY58.72-0.64
-1.08%
Ryanair Holdings plc
GALT2.42-0.19
-7.28%
Galectin Therapeutics